Brief: Cyclerion Therapeutics - Preliminary Unaudited Cash, Cash Equivalents And Restricted Cash Balance As Of Dec 31, 2021 Was About $58 Million

Korsana Biosciences

13/01/2021 15:33

Jan 13 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION THERAPEUTICS - PRELIMINARY UNAUDITED CASH, CASH
EQUIVALENTS AND RESTRICTED CASH BALANCE AS OF DEC 31, 2021 WAS
ABOUT $58 MILLION

Source text for Eikon: [https://bit.ly/3snDDag]
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))